Shares of DBV Technologies S.A. DBVT were up 22% on Dec 23 after the company announced that the FDA has lifted the partial clinical hold on its VITESSE (Viaskin Peanut Immunotherapy Trial to Evaluate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results